Implication of the age in the clinical spectrum of giant cell arteritis

Clinical and Experimental Rheumatology

Volumn 26, Issue 3 SUPPL. 49, 2008, Pages

  Lopez Diaz, Maria J ^a   Llorca, Javier ^b   Gonzalez Juanatey, Carlos ^a   Peña Sagredo, Jose L ^c   Martin, Javier ^d   Gonzalez Gay, Miguel A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d CSIC   (Spain)

Author keywords

Age; Clinical manifestations; Epidemiology; Giant cell (temporal) arteritis; Temporal artery biopsy

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISONE;

AGE DISTRIBUTION; AGED; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL BIOPSY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DELAYED DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; VISUAL IMPAIRMENT;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BLOOD SEDIMENTATION; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GIANT CELL ARTERITIS; HUMANS; MALE; MIDDLE AGED; POLYMYALGIA RHEUMATICA; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES;

EID: 52049085544     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. MAKSIMOWICZ-MCKINNON K, HOFFMAN GS: Large vessel vasculitis. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S58-9.
2. DASGUPTA B, HASSAN N: British Society for Rheumatology Guidelines Group. Giant cell arteritis: Recent advances and guidelines for management. Clin Exp Rheumatol 2007; 25 (Suppl 44): S62-5.
3. SALVARANI C, CANTINI F, BOIARDI L, HUNDER GG: Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-71.
4. PIPITONE N, BOIARDI L, BAJOCCHI G, SALVARANI C: Long-term outcome of giant cell arteritis. Clin Exp Rheumatol. 2006; 24(Suppl. 41): S65-70.
5. GONZALEZ-GAY MA, GARCIA-PORRUA C: Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001; 27: 729-49.
6. GONZALEZ-GAY MA, GARCIA-PORRUA C: Systemic vasculitides. Best Pract Res Clin Rheumatol. 2002; 16: 833-45.
7. LEVINE SM, HELLMANN GB: Giant cell arteritis. Curr Opin Rheumatol. 2002; 14: 3-10.
8. HUSTOA KA, HUNDER GG, LIE JT, KENNEDY RH, ELVEBACK LR: Arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978; 88: 162-7.
9. BARRIER J, PION P, MASSARI R, PELTIER P, ROJOUAN J, GROLLEAU JY: Approche épidémiologique de la maladie de Horton dans le département de Loire-Atlantique: 110 cas en 10 ans (1970-1979). Rev Med Interne 1983; 3: 13-20.
10. NESHER G, RUBINOW A, SONNENBLICK M: Trends in the clinical presentation of temporal arteritis in Israel: Reflection of increased physician awareness. Clin Rheumatol 1996; 15: 483-5.
11. GONZALEZ-GAY MA, GARCÍA-PORRUA C: Systemic vasculitis in adults in Northwestern Spain, 1988-1997: Clinical and epidemiologic aspects. Medicine (Baltimore) 1999; 78: 292-308.
12. GRAN JT, MYKLEBUST G: The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: A prospective study 1987-94. J Rheumatol 1997; 24: 1739-43.
13. SALVARANI C, GABRIEL SE, O'FALLON WM, HUNDER GG: The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123: 192-4.
14. SALVARANI C, MACCHIONI P, ZIZZI F et al.: Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991; 34: 351-6.
15. SONNENBLICK M, NESHER G, FRIEDLANDER Y, RUBINOW A: Giant cell arteritis in Jerusalem: A 12-year epidemiological study. Br J Rheumatol 1994; 33: 938-41.
16. BAS-LANDO M, BREUER GS, BERKUN Y, MATES M, SONNENBLICK M, NESHER G: The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S15-7.
17. HELLMANN DB: TAmporal arteritis: a cough, toothache, and tongue infarction. JAMA. 2002; 287: 2996-3000.
18. LEE MS, SMITH SD, GALOR A, HOFFMAN GS: Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006; 54: 3306-9.
19. GONZALEZ-GAY MA, GARCIA-PORRUA C, RIVAS MJ, RODRIGUEZ-LEDO P, LLORCA J: Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: Trend over an 18 year period. Ann Rheum Dis 2001; 60: 367-71.
20. SALVARANI C, CROWSON CS, O'FALLON WM, HUNGER GG, GABRIEL SE: Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004; 51: 264-8.
21. GONZALEZ-GAY MA, GARCIA-PORRUA C, AMOR-DORADO JC, LLORCA J: Influence of age, sex, and place of residence on clinical expression of giant cell arteritis in northwest Spain. J Rheumatol 2003; 30: 1548-51.
22. GONZALEZ-GAY MA, MIRANDA-FILLOY JA, LOPEZ-DIAZ MJ et al.: Giant cell arteritis in northwestern Spain: A 25-year epidemiologic study. Medicine (Baltimore) 2007; 86: 61-8.
23. GONZALEZ-GAY MA: Giant cell arteritis and pTlymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004; 33: 289-93.
24. GONZALEZ-GAY MA, BARROS S, LOPEZ-DIAZ MJ, GARCIA-PORRUA C, SANCHEZ-ANDRADE A, LLORCA J: Giant cell arteritis: Disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore). 2005; 84: 269-76.
25. GONZALEZ-GAY MA, GARCIA-PORRUA C, PIÑEIRO A, PEGO-REIGOSA R, LLORCA J, HUNGER GG: Aortic aneurysm and dissection in biopsy-proven giant cell arteritis patients from Northwest Spain. A population-based study. Medicine (Baltimore) 2004; 83: 335-41.
26. JENNETTE JC, FALK RJ: The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 2007; 25 (Suppl. 44): S52-6.
27. GONZALEZ-GAY MA, GARCIA-PORRUA C. VAZQUEZ-CARUNCHO M, DABABNEH A, HAJEER A, OLLIER WE: The spectrum of polymyalgia rheumatica in Northwestern Spain: Incidence and analysis of variables associated with relapse in a ten-year-study. J Rheumatol 1999; 26: 1326-32.
28. GONZALEZ-GAY MA, ALONSO MD, AGUERO JJ, BAL M, FERNANDEZ-CAMBLOR B, SANCHEZ-ANDRADE A: Temporal Arteritis in a Northwestern Area of Spain: Study of 57 biopsy proven patients. J Rheumatol 1992; 19: 277-80.
29. GONZALEZ-GAY MA, GARCIA-PORRUA C, VAZQUEZ-CARUNCHO M: Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998; 25: 1750-5.
30. GONZALEZ-GAY MA: The diagnosis and management of patients with giant cell arteritis. J Rheumatol 2005; 32: 1186-8.
31. GONZALEZ-GAY MA, LOPEZ-DIAZ MJ, BARROS S et al.: Giant cell arteritis: Laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 2005; 84: 277-90.
32. GONZALEZ-GAY MA, BLANCO R, SANCHEZ-ANDRADE A, VAZQUEZ-CARUNCHO M: Giant cell arteritis in Lugo, Spain: A more frequent disease with fewer classic features. J Rheumatol 1997; 24: 2166-70.
33. GONZALEZ-GAY MA, BLANCO R, ABRAIRA V et al: Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997; 24: 2171-6.
34. GONZALEZ-GAY MA, PIÑEIRO A. GOMEZ-GIGIREY A et al.: Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004; 83: 342-7.
35. GONZALEZ-GAY MA, GARCIA-PORRUA C, AMOR-DORADO JC, LLORCA J: Fever in biopsy-proven giant cell arteritis: Clinical implications in a defined population. Arthritis Rheum 2004; 51: 652-5.
36. GONZALEZ-GAY MA, GARCIA-PORRUA C, SALVARANI C, HUNGER GG: Diagnostic approach in a patient presenting with polymyalgia. Clin Exp Rheumatol 1999; 17: 276-8.
37. GONZALEZ-GAY MA, GARCIA-PORRUA C, SALVARANI C, OLIVIERI I, HUNDER GG: The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000; 27: 2179-84.
38. GONZALEZ-GAY MA, GARCIA-PORRUA C, LLORCA J et al.: Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000; 79: 283-92.
39. HUNGER GG, BLOCH GA, MICHEL BA et al.: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-8.
40. NARVAEZ J, NOLLA-SOLE JM, CLAVAGUERA MT, VALVERDE-GARCIA J, ROIG-ESCOFET D: Temporal arteritis and polymyalgia rheumatica in north-eastern Spain: clinical spectrum and relationship over a 15 year period. Joint Bone Spine 2003; 70: 33-9.
41. DABABNEH A, GONZALEZ-GAY MA, GARCIA-PORRUA C, HAJEER A, THOMSON W, OLLIER W: Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998; 25: 2140-5.
42. GONZALEZ-GAY MA: Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001; 3: 154-7.
43. GONZALEZ-GAY MA, AMOLI MM, GARCIA-PORRUA C, OLLIER WE: Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003; 33: 38-48.
44. NORDBORG E, NORDEORG C: Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology (Oxford) 2003; 42: 413-21.
45. GRUBECK-LOEBENSTEIN B, WICK G: The aging of the immune system. Adv Immunol 2002; 80: 243-84.
46. CHIKANZA IC, GROSSMAN AB: Reciprocal interactions between the neuroendocrine and immune systems during inflammation. Rheum Dis Clin North Am 2000; 26: 693-711.
47. STRAUB RH, KONECNA L, HRACH S et al.: Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83: 2012-7.
48. DEUSCHLE M, GOTTHARDT U, SCHWEIGER U et al.: With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Sci 1997; 61: 2239-46.
49. NARVAEZ J, BERNAD B, DIAZ TORNE C et al.: Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis. J Rheumatol 2006; 33: 1293-8.
50. GONZALEZ-GAY MA, HAJEER AH, DABABNEH A et al.: Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 2002; 20: 133-8.